PT94628A - PROCESS FOR THE PREPARATION OF FORMULATIONS CONTAINING SOLUTIONS IN WATER OF DELAYED LIBERTACAO - Google Patents

PROCESS FOR THE PREPARATION OF FORMULATIONS CONTAINING SOLUTIONS IN WATER OF DELAYED LIBERTACAO

Info

Publication number: PT94628A
Authority: PT; Portugal
Prior art keywords: libertacao; delayed; preparation; water; formulations containing
Prior art date: 1989-07-07

Application number

PT94628A

Other languages

Portuguese (pt)

Other versions

PT94628B (en

Inventor

David Bodmer

Jones Wing Fong

Thomas Kissel

Hawkins Valliant Maulding

Oscar Nagele

Jane Edna Pearson

Original Assignee

Sandoz Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-07-07

Filing date

1990-07-06

Publication date

1991-03-20

1990-07-06 Application filed by Sandoz Sa filed Critical Sandoz Sa

1991-03-20 Publication of PT94628A publication Critical patent/PT94628A/en

1997-06-30 Publication of PT94628B publication Critical patent/PT94628B/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/095—Oxytocins; Vasopressins; Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/23—Calcitonins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/31—Somatostatins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Hematology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Emergency Medicine (AREA)
Obesity (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Cosmetics (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

PT94628A 1989-07-07 1990-07-06 PROCESS FOR THE PREPARATION OF FORMULATIONS CONTAINING SOLUTIONS IN WATER OF DELAYED LIBERTACAO PT94628B (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US37702389A	1989-07-07	1989-07-07
US41134789A	1989-09-22	1989-09-22

Publications (2)

Publication Number	Publication Date
PT94628A true PT94628A (en)	1991-03-20
PT94628B PT94628B (en)	1997-06-30

Family

ID=27007654

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT94628A PT94628B (en)	1989-07-07	1990-07-06	PROCESS FOR THE PREPARATION OF FORMULATIONS CONTAINING SOLUTIONS IN WATER OF DELAYED LIBERTACAO

Country Status (27)

Country	Link
JP (5)	JPH0832624B2 (en)
KR (2)	KR100303681B1 (en)
AT (1)	AT406225B (en)
AU (2)	AU641407B2 (en)
BE (1)	BE1004486A3 (en)
CA (1)	CA2020477C (en)
CH (1)	CH685230A5 (en)
CY (1)	CY1965A (en)
DE (2)	DE4021517B4 (en)
DK (1)	DK175849B1 (en)
FI (3)	FI108611B (en)
FR (1)	FR2649319A1 (en)
GB (2)	GB2234896B (en)
GR (1)	GR1001121B (en)
HK (2)	HK97695A (en)
HU (2)	HU221294B1 (en)
IE (2)	IE64411B1 (en)
IL (3)	IL131880A (en)
IT (1)	IT1241460B (en)
LU (1)	LU87764A1 (en)
MY (1)	MY106722A (en)
NL (1)	NL195027C (en)
NO (2)	NO302928B1 (en)
NZ (1)	NZ234384A (en)
PT (1)	PT94628B (en)
SE (1)	SE512992C2 (en)
SG (1)	SG26416G (en)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4990336A (en) *	1989-02-08	1991-02-05	Biosearch, Inc.	Sustained release dosage form
YU48420B (en) *	1991-03-25	1998-07-10	Hoechst Aktiengesellschaft	PROCEDURE FOR OBTAINING BIOLOGICAL DEGRADABLE MICROPARTICLES WITH LONG TERM ACTION
CH683149A5 (en) *	1991-07-22	1994-01-31	Debio Rech Pharma Sa	Process for the preparation of microspheres of a biodegradable polymeric material.
US6013853A (en) *	1992-02-14	2000-01-11	The University Of Texas System	Continuous release polymeric implant carrier
US5876452A (en) *	1992-02-14	1999-03-02	Board Of Regents, University Of Texas System	Biodegradable implant
DE4218510A1 (en) *	1992-06-02	1993-12-09	Pharmatech Gmbh	Process for the preparation of biodegradable polyesters
AU4198793A (en) †	1992-07-24	1994-01-27	Takeda Chemical Industries Ltd.	Microparticle preparation and production thereof
EP0626170A3 (en) *	1993-05-10	1996-03-27	Sandoz Ltd	Stabilisation of pharmacologically active compounds in sustained release compositions.
GB9310781D0 (en) *	1993-05-25	1993-07-14	Davis Stanley S	Preparation of microparticles
US5603960A (en) *	1993-05-25	1997-02-18	O'hagan; Derek T.	Preparation of microparticles and method of immunization
DK0729357T3 (en)	1993-11-19	2005-06-06	Janssen Pharmaceutica Nv	Microencapsulated 1,2-benzazoles
US6270795B1 (en)	1995-11-09	2001-08-07	Microbiological Research Authority	Method of making microencapsulated DNA for vaccination and gene therapy
EP0965336A1 (en)	1995-11-09	1999-12-22	Microbiological Research Authority	Microencapsulated DNA for gene therapy
DE19545257A1 (en)	1995-11-24	1997-06-19	Schering Ag	Process for the production of morphologically uniform microcapsules and microcapsules produced by this process
US5817343A (en) *	1996-05-14	1998-10-06	Alkermes, Inc.	Method for fabricating polymer-based controlled-release devices
US5968895A (en) *	1996-12-11	1999-10-19	Praecis Pharmaceuticals, Inc.	Pharmaceutical formulations for sustained drug delivery
US6126919A (en)	1997-02-07	2000-10-03	3M Innovative Properties Company	Biocompatible compounds for pharmaceutical drug delivery systems
GB9810236D0 (en)	1998-05-13	1998-07-08	Microbiological Res Authority	Improvements relating to encapsulation of bioactive agents
US6632457B1 (en) *	1998-08-14	2003-10-14	Incept Llc	Composite hydrogel drug delivery systems
US7107268B1 (en)	1998-11-12	2006-09-12	Printable Technologies, Inc.	Centralized system and method for managing enterprise operations
US6226656B1 (en)	1998-11-12	2001-05-01	Sourcefinder, Inc.	System and method for creating, generating and processing user-defined generic specs
US6204308B1 (en)	1999-03-01	2001-03-20	Novartis Ag	Organic compounds
EP1044683A1 (en)	1999-04-15	2000-10-18	Debio Recherche Pharmaceutique S.A.	One-step dispersion method for the microencapsulation of water soluble substances
US6461631B1 (en) *	1999-11-16	2002-10-08	Atrix Laboratories, Inc.	Biodegradable polymer composition
KR100392501B1 (en) *	2000-06-28	2003-07-22	동국제약 주식회사	Preparation Method for Sustained Release Microparticles by Multiple Emulsion Method and Micropartic les Thereof
US6824822B2 (en) *	2001-08-31	2004-11-30	Alkermes Controlled Therapeutics Inc. Ii	Residual solvent extraction method and microparticles produced thereby
AU2002232824A1 (en)	2000-12-21	2002-07-01	Inhale Therapeutic Systems, Inc.	Induced phase transition method for the production of microparticles containing hydrophobic active agents
US20040097419A1 (en) *	2002-11-19	2004-05-20	Holger Petersen	Organic compounds
PE20050285A1 (en) *	2003-06-24	2005-06-09	Novartis Ag	PHARMACEUTICAL COMPOSITION INCLUDING CYCLIC ANALOGS OF SOMATOSTATIN
ES2600554T3 (en) *	2003-07-18	2017-02-09	Oakwood Laboratories L.L.C.	Prevention of polymer molecular weight reduction, impurity formation and gelation in polymeric compositions
MY158342A (en) *	2003-11-14	2016-09-30	Novartis Ag	Pharmaceutical composition
KR20060129394A (en) *	2004-02-26	2006-12-15	독립행정법인 과학기술진흥기구	Sustained release particulate preparations for injection of proteinaceous drugs and preparation method thereof
DE102004053373A1 (en) *	2004-11-02	2006-05-04	Justus-Liebig-Universität Giessen	Invention relating to nano / meso-fiber anisometric particles in the form of nano / meso-fiber tubes, cables and their curved or branched modifications
KR100741867B1 (en) *	2005-07-05	2007-07-24	전북대학교산학협력단	Method of Preparation of Double Layered Microspheres Using Oil-in-water and Solvent Evaporation
AR058591A1 (en) *	2005-12-22	2008-02-13	Novartis Ag	FORMULATION OF SUSTAINED RELEASE THAT INCLUDES OCTREOTIDE AND TWO OR MORE POLYMACTIDE-COGLICOLID POLYMERS
KR100816065B1 (en) *	2006-11-27	2008-03-24	동국제약 주식회사	Method for preparing sustained release microcapsules with excellent initial release control characteristics and microcapsules prepared by the same
AU2009209594A1 (en)	2008-01-30	2009-08-06	Novartis Ag	Sustained release formulation comprising octreotide and three linear polylactide-co-glycolide polymers
USRE49251E1 (en)	2010-01-04	2022-10-18	Mapi Pharma Ltd.	Depot systems comprising glatiramer or pharmacologically acceptable salt thereof
EP2621474A2 (en) *	2010-09-30	2013-08-07	Evonik Corporation	Emulsion method for preparing low residual solvent microparticles
JP5808413B2 (en) *	2010-09-30	2015-11-10	エボニックコーポレイションＥｖｏｎｉｋＣｏｒｐｏｒａｔｉｏｎ	Method for removing residual organic solvent from fine particles
TW201605488A (en)	2013-10-15	2016-02-16	大塚製藥股份有限公司	Drug for preventing and/or treating polycystic kidney disease
KR102464650B1 (en)	2016-05-03	2022-11-10	엘에스일렉트릭(주)	Current limiting device of circuit breaker
US12097292B2 (en)	2016-08-28	2024-09-24	Mapi Pharma Ltd.	Process for preparing microparticles containing glatiramer acetate
CA3050086A1 (en)	2017-03-26	2018-10-04	Mapi Pharma Ltd.	Glatiramer depot systems for treating progressive forms of multiple sclerosis

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3773919A (en) *	1969-10-23	1973-11-20	Du Pont	Polylactide-drug mixtures
CH644768A5 (en) *	1977-08-25	1984-08-31	Sandoz Ag	METHOD FOR PRODUCING MICROBALLS.
US4622244A (en) *	1979-09-04	1986-11-11	The Washington University	Process for preparation of microcapsules
US4293539A (en) *	1979-09-12	1981-10-06	Eli Lilly And Company	Controlled release formulations and method of treatment
EP0029579B1 (en) *	1979-11-27	1983-02-16	Sandoz Ag	Polypeptides, processes for their production, pharmaceutical compositions comprising said polypeptides and their use
US4389330A (en) *	1980-10-06	1983-06-21	Stolle Research And Development Corporation	Microencapsulation process
PH19942A (en) *	1980-11-18	1986-08-14	Sintex Inc	Microencapsulation of water soluble polypeptides
US4675189A (en) *	1980-11-18	1987-06-23	Syntex (U.S.A.) Inc.	Microencapsulation of water soluble active polypeptides
IE52535B1 (en) *	1981-02-16	1987-12-09	Ici Plc	Continuous release pharmaceutical compositions
ATE37983T1 (en) *	1982-04-22	1988-11-15	Ici Plc	DELAYED RELEASE AGENT.
CH656884A5 (en) *	1983-08-26	1986-07-31	Sandoz Ag	POLYOLESTERS, THEIR PRODUCTION AND USE.
US4485101A (en) *	1983-10-11	1984-11-27	Administrators Of The Tulane Educational Fund	Peptides
JPH0657658B2 (en) *	1985-04-11	1994-08-03	住友製薬株式会社	Sustained release formulation
JPS60100516A (en) *	1983-11-04	1985-06-04	Takeda Chem Ind Ltd	Preparation of sustained release microcapsule
GB8331158D0 (en) *	1983-11-22	1983-12-29	British Telecomm	Metal/semiconductor deposition
JPS60181029A (en) *	1984-02-29	1985-09-14	Toyo Jozo Co Ltd	Preparation of sustained release preparation
CH660302A5 (en) *	1984-10-17	1987-04-15	Debiopharm Sa	HETEROGENEOUS PHASE MICRO-ENCAPSULATION PROCESS OF WATER-SOLUBLE DRUG SUBSTANCES.
EP0190833B1 (en) *	1985-02-07	1991-03-27	Takeda Chemical Industries, Ltd.	Method for producing microcapsule
US4725577A (en) *	1985-04-25	1988-02-16	Administrators Of The Tulane Educational Fund	Biologically active lysine containing octapeptides
CH665558A5 (en) *	1985-10-09	1988-05-31	Debiopharm Sa	Phase sepn. prodn. of microcapsules for water soluble pharmaceuticals - using fluoro-substd. aliphatic hydrocarbon as non-solvent in the hardening stage
JP2539789B2 (en) *	1986-03-06	1996-10-02	日本原子力研究所	Process for producing sustained-release drug complex composed of polylactone
GB2193891B (en) *	1986-08-18	1990-07-25	Sandoz Ltd	Nasal pharmaceutical composition containing a somatostatin anologue.
JPH0725689B2 (en) *	1986-10-07	1995-03-22	中外製薬株式会社	Sustained-release preparation containing granulocyte colony-stimulating factor
GB2209937B (en) *	1987-09-21	1991-07-03	Depiopharm S A	Water insoluble polypeptides
CH672887A5 (en) *	1987-10-14	1990-01-15	Debiopharm Sa
DE3738228A1 (en) *	1987-11-11	1989-05-24	Hoechst Ag	METHOD FOR PRODUCING BIODEGRADABLE MICRO-CAPSULES OF WATER-SOLUBLE PEPTIDES AND PROTEINS AND MICRO-CAPSULES OBTAINED BY THIS PROCESS
JP2653255B2 (en) *	1990-02-13	1997-09-17	武田薬品工業株式会社	Long-term sustained release microcapsules

1990
- 1990-06-25 HU HU974/90A patent/HU221294B1/en unknown
- 1990-07-03 GB GB9014704A patent/GB2234896B/en not_active Expired - Lifetime
- 1990-07-03 SG SG1995907374A patent/SG26416G/en unknown
- 1990-07-05 NZ NZ234384A patent/NZ234384A/en unknown
- 1990-07-05 IE IE43894A patent/IE64411B1/en not_active IP Right Cessation
- 1990-07-05 IL IL13188090A patent/IL131880A/en active IP Right Grant
- 1990-07-05 SE SE9002364A patent/SE512992C2/en not_active IP Right Cessation
- 1990-07-05 CA CA002020477A patent/CA2020477C/en not_active Expired - Lifetime
- 1990-07-05 NL NL9001537A patent/NL195027C/en not_active IP Right Cessation
- 1990-07-05 IE IE243590A patent/IE64216B1/en not_active IP Right Cessation
- 1990-07-05 AU AU58746/90A patent/AU641407B2/en not_active Expired
- 1990-07-05 NO NO903001A patent/NO302928B1/en not_active IP Right Cessation
- 1990-07-05 IT IT48113A patent/IT1241460B/en active IP Right Grant
- 1990-07-05 GR GR900100513A patent/GR1001121B/en not_active IP Right Cessation
- 1990-07-05 BE BE9000693A patent/BE1004486A3/en not_active IP Right Cessation
- 1990-07-05 IL IL13188190A patent/IL131881A/en active IP Right Grant
- 1990-07-05 FR FR9008718A patent/FR2649319A1/en active Granted
- 1990-07-05 CH CH2249/90A patent/CH685230A5/en not_active IP Right Cessation
- 1990-07-05 DK DK199001625A patent/DK175849B1/en not_active IP Right Cessation
- 1990-07-05 IL IL9498390A patent/IL94983A/en active IP Right Grant
- 1990-07-06 JP JP2177665A patent/JPH0832624B2/en not_active Expired - Lifetime
- 1990-07-06 FI FI903429A patent/FI108611B/en active IP Right Grant
- 1990-07-06 AT AT0144090A patent/AT406225B/en not_active IP Right Cessation
- 1990-07-06 MY MYPI90001133A patent/MY106722A/en unknown
- 1990-07-06 DE DE4021517A patent/DE4021517B4/en not_active Expired - Lifetime
- 1990-07-06 KR KR1019900010224A patent/KR100303681B1/en not_active IP Right Cessation
- 1990-07-06 DE DE4042752A patent/DE4042752B4/en not_active Expired - Lifetime
- 1990-07-06 PT PT94628A patent/PT94628B/en not_active IP Right Cessation
- 1990-07-09 LU LU87764A patent/LU87764A1/en unknown
1993
- 1993-03-25 GB GB9306204A patent/GB2265311B/en not_active Expired - Lifetime
1995
- 1995-04-18 JP JP7116539A patent/JPH07309897A/en active Pending
- 1995-04-18 JP JP7116486A patent/JP2931773B2/en not_active Expired - Lifetime
- 1995-06-15 HK HK97695A patent/HK97695A/en not_active IP Right Cessation
- 1995-06-28 HU HU95P/P00523P patent/HU211602A9/en unknown
- 1995-06-29 AU AU23321/95A patent/AU687553B2/en not_active Expired
- 1995-08-15 JP JP7228646A patent/JPH08198771A/en active Pending
1996
- 1996-10-31 HK HK197496A patent/HK197496A/en not_active IP Right Cessation
1997
- 1997-07-04 CY CY196597A patent/CY1965A/en unknown
1998
- 1998-08-26 NO NO19983923A patent/NO320444B1/en unknown
1999
- 1999-09-14 KR KR1019990039209A patent/KR100442931B1/en not_active IP Right Cessation
2000
- 2000-01-12 FI FI20000060A patent/FI109334B/en active
- 2000-01-12 FI FI20000059A patent/FI109543B/en active
2001
- 2001-01-15 JP JP2001006486A patent/JP2001233897A/en active Pending

Also Published As

Publication number	Publication date
HUT54037A (en)	1991-01-28
JP2931773B2 (en)	1999-08-09
JPH08198771A (en)	1996-08-06
FI903429A0 (en)	1990-07-06
PT94628B (en)	1997-06-30
CA2020477C (en)	2000-11-21
HU221294B1 (en)	2002-09-28
GB2265311B (en)	1994-02-09
KR910002430A (en)	1991-02-25
SE9002364L (en)	1991-01-08
IT9048113A0 (en)	1990-07-05
GB9306204D0 (en)	1993-05-19
DK162590A (en)	1991-01-08
FI109334B (en)	2002-07-15
IL94983A (en)	1999-08-17
CY1965A (en)	1997-07-04
IT9048113A1 (en)	1992-01-05
GR1001121B (en)	1993-04-28
DE4042752B4 (en)	2009-05-07
NZ234384A (en)	1994-05-26
IT1241460B (en)	1994-01-17
CH685230A5 (en)	1995-05-15
DE4021517B4 (en)	2009-04-09
FR2649319B1 (en)	1994-12-09
NO320444B1 (en)	2005-12-05
LU87764A1 (en)	1992-03-11
FI109543B (en)	2002-08-30
GB9014704D0 (en)	1990-08-22
IL131880A (en)	2001-12-23
GB2234896B (en)	1994-01-19
SE9002364D0 (en)	1990-07-05
AU5874690A (en)	1991-01-10
HK97695A (en)	1995-06-23
IE902435A1 (en)	1991-02-13
IE64216B1 (en)	1995-07-26
IL94983A0 (en)	1991-06-10
IL131881A (en)	2001-12-23
IE64411B1 (en)	1995-08-09
HU903974D0 (en)	1990-11-28
NO903001L (en)	1991-01-08
KR100303681B1 (en)	2002-05-16
NL195027C (en)	2003-12-02
DK162590D0 (en)	1990-07-05
GB2234896A (en)	1991-02-20
AU641407B2 (en)	1993-09-23
AU2332195A (en)	1995-09-07
FI20000059A (en)	2000-01-12
BE1004486A3 (en)	1992-12-01
CA2020477A1 (en)	1991-01-08
HK197496A (en)	1996-11-08
JP2001233897A (en)	2001-08-28
FR2649319A1 (en)	1991-01-11
JPH07285853A (en)	1995-10-31
JPH0368511A (en)	1991-03-25
NL9001537A (en)	1991-02-01
DK175849B1 (en)	2005-03-29
JPH07309897A (en)	1995-11-28
NO302928B1 (en)	1998-05-11
GR900100513A (en)	1991-12-10
AT406225B (en)	2000-03-27
DE4021517A1 (en)	1991-01-17
SE512992C2 (en)	2000-06-12
FI108611B (en)	2002-02-28
NO983923L (en)	1991-01-08
NL195027B (en)	2003-08-01
ATA144090A (en)	1999-08-15
HU211602A9 (en)	1995-12-28
GB2265311A (en)	1993-09-29
SG26416G (en)	1995-09-01
KR100442931B1 (en)	2004-08-02
MY106722A (en)	1995-07-31
JPH0832624B2 (en)	1996-03-29
FI20000060A (en)	2000-01-12
NO983923D0 (en)	1998-08-26
AU687553B2 (en)	1998-02-26
NO903001D0 (en)	1990-07-05

Publication	Publication Date	Title
PT94628A (en)	1991-03-20	PROCESS FOR THE PREPARATION OF FORMULATIONS CONTAINING SOLUTIONS IN WATER OF DELAYED LIBERTACAO
PT88194A (en)	1989-06-30	PROCESS FOR THE PREPARATION OF MICROBULID MICROBICIDES OF ISOTIAZOLONES WITH SMALL SOLUBILITY IN WATER
BR8306873A (en)	1984-07-24	PROCESS FOR THE PREPARATION OF GRANULATES DISPERSABLE IN WATER AND GRANULATES OBTAINED
PT92919A (en)	1990-07-31	PROCESS FOR THE PREPARATION OF BIS-AZABICYLIC ACID ANSIOLITIC AGENTS
BR9004644A (en)	1991-09-10	ENAMEL FOR DILUIVELY NAILS IN WATER
PT90293A (en)	1989-11-10	PROCESS FOR THE PREPARATION OF MACROLIDS
PT757034E (en)	2002-09-30	PROCESS FOR THE PREPARATION OF TOLUENODI-ISOCYANATE SPECIAL MIXTURES OF TOLUENODIAMINE AND WATER AND ITS USE IN THE PREPARATION OF TOLUENODI-ISOCYANATE
BR8902015A (en)	1989-12-05	PHENOL PREPARATION PROCESS
BR8906327A (en)	1990-08-21	PROCESS FOR THE PREPARATION OF ORGANOCLOROSILANS
PT90630A (en)	1989-11-30	PROCESS FOR THE PREPARATION OF EFFECTIVELY DISPERSIBLE PSILIUM COMPOSITIONS
PT92638A (en)	1990-06-29	PROCESS FOR THE PREPARATION OF MONO-N-ACKYLATED POLYMAZAMACROCYCLES
PT90854A (en)	1989-12-29	PROCESS FOR THE PREPARATION OF 1-ARYL-2-NAFTOYLAMINS
PT95542A (en)	1991-08-14	PROCESS FOR THE PREPARATION OF PHENETHANOLAMINE DERIVATIVES
BR8905441A (en)	1990-10-23	COMPOUND PREPARATION PROCESS
PT92365A (en)	1990-05-31	PROCESS FOR THE PREPARATION OF (S) -ALFA-ETHYL-2-OXO-1-PYRROLIDINEACETAMIDE
BR9001503A (en)	1991-04-16	PROCESS FOR THE PREPARATION OF ALKYL-HALOGENOSILANS
BR9205129A (en)	1993-06-29	PROCESS FOR THE PREPARATION OF PURE ISOCIANATES
BR8507201A (en)	1987-08-04	A PROCESS FOR WATER ABSORPTION HAVING A PH LESS THAN FOUR
BR9003014A (en)	1992-01-07	PROCESS TO DISINFECT RESIDUAL WATER
BR8603088A (en)	1987-02-17	WATER VAPOR FOAM PROCESS
PT82950B (en)	1989-01-30	PROCESS FOR THE PREPARATION OF AQUOSUS ANTIMICROBIAL SOLUTIONS OF ISOTIAZOLONE
BR9004059A (en)	1991-09-03	PROCESS FOR THE PREPARATION OF LIQUID LIQUID FORMULATIONS OF PROTEOLITICALLY EFFECTIVE ENZYMES
PT92171A (en)	1990-05-31	N-PHOSPONOMETHYL-GLYCINE PREPARATION PROCESS
BR8902030A (en)	1989-12-05	PROCESS FOR THE PREPARATION OF N-PHOSPHONOMETHYLGLYCIN
PT89954B (en)	1994-05-31	PROCESS FOR THE PREPARATION OF PYRROLOKINOLINE-AND-PYRROLOPHENOTIAZINE-CARBOXAMIDES AND RELATED COMPOUNDS

Legal Events

Date	Code	Title	Description
1991-03-20	BB1A	Laying open of patent application	Effective date: 19901011
1997-06-30	FG3A	Patent granted, date of granting	Effective date: 19970331
1998-01-30	PC3A	Transfer or assignment	Free format text: 971017 NOVARTIS AG CH
2012-04-10	MM4A	Annulment/lapse due to non-payment of fees, searched and examined patent	Free format text: MAXIMUM VALIDITY LIMIT REACHED Effective date: 20120402